ArticleNeuro-oncology2025

Phase 1 dose-escalation trial using convection-enhanced delivery of radio-immunotheranostic 124I-Omburtamab for diffuse intrinsic pontine glioma.

Mark M Souweidane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.